2022: Reflecting on a Remarkable Year of Progress
Reflecting on a Remarkable Year of Progress: A Letter from Roivant Social Ventures President & CEO Lindsay Androski
Roivant Social Ventures Publishes Global Access Scorecard to Guide Impact Investors in Making Equitable Investment Decisions
Roivant Social Ventures Publishes Global Access Scorecard to Guide Impact Investors in Making Equitable Investment Decisions
RSV Named Finalist for Venture Philanthropy Award
The Gregor G. Peterson Prize in Venture Philanthropy is awarded annually to a trailblazing start-up in the non-profit sector.
Roivant Social Ventures and Vanderbilt University Medical Center announce collaboration to develop therapies for traditionally underserved populations and diseases.
Vanderbilt University Medical Center (VUMC) and Roivant Social Ventures (RSV) announced an intention to collaborate in developing therapies…
Fierce Biotech Feature: “From whiteboard to white coat: Roivant Social Ventures teams up with San Diego drug discovery center to bolster diversity in biopharma” by Max Bayer
Roivant Social Venture's new program is set to launch its first cohort of students in fall 2023. (Advarra)
Roivant Social Ventures and Sanford Burnham Prebys Announce Groundbreaking Partnership to Increase Diversity & Inclusion in Biopharma
Roivant Social Ventures announced a major collaboration with Sanford Burnham Prebys, San Diego’s prestigious medical discovery institute…
FasterCures, a Center of the Milken Institute, welcomes RSV to TRAIN Network
The Research Acceleration and Innovation Network (TRAIN) is an affinity network of foundations interested in taking a more strategic and entrepreneurial approach—what some refer to as “venture philanthropy”—to their role as funders of medical research.